Cargando…

Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017

The role of perioperative chemotherapy associated with radical cystectomy (RC) for muscle-invasive bladder cancer has been analyzed in several landmark randomized controlled trials (RCTs) over the past decades. With regard to neoadjuvant chemotherapy (NAC), a meta-analysis of level 1 evidence and lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pradère, Benjamin, Thibault, Constance, Vetterlein, Malte W., Leow, Jeffrey J., Peyronnet, Benoit, Rouprêt, Morgan, Seisen, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760386/ https://www.ncbi.nlm.nih.gov/pubmed/29354492 http://dx.doi.org/10.21037/tau.2017.09.12

Ejemplares similares

Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic
por: Lenfant, Louis, et al.
Publicado: (2020)

Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma
por: Khene, Zine-Eddine, et al.
Publicado: (2016)

Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study
por: Brennan, Kelly, et al.
Publicado: (2018)

Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer
por: Diamant, Elliott, et al.
Publicado: (2022)

Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder
por: Nayyar, Rishi, et al.
Publicado: (2011)

Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
por: Zucali, Paolo Andrea, et al.
Publicado: (2020)

Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers
por: Walker, Melanie, et al.
Publicado: (2018)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797
por: Diamant, Elliott, et al.
Publicado: (2022)

Trends in the placement of penile prostheses over the last 17 years in France
por: Léon, Priscilla, et al.
Publicado: (2015)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee
por: Masson-Lecomte, Alexandra, et al.
Publicado: (2022)

Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States
por: Seisen, Thomas, et al.
Publicado: (2023)

Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
por: Janisch, Florian, et al.
Publicado: (2019)

Dengue — Quo tu et quo vadis?
por: Chen, Rubing, et al.
Publicado: (2011)

Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023)

Letter to the Editor on the systematic review “Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer”
por: Roupret, Morgan, et al.
Publicado: (2023)

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
por: Hawkes, Eliza A, et al.
Publicado: (2012)

Risk stratification for upper tract urinary carcinoma
por: Benamran, Daniel, et al.
Publicado: (2020)

Quo vadis?
por: Sienkiewicz, Henryk, 1846-1916
Publicado: (1943)

“Quo Vadis?”
por: Bereen, J. F.
Publicado: (1964)

Quo vadis? /
por: Sienkiewicz, Henryk, 1846-1916

Quo Vadis?
Publicado: (1902)

Quo Modo?
Publicado: (1856)

Quo Vadis?
por: Happel, T. J.
Publicado: (1899)

Gastroenterology Meets Machine Learning: Status Quo and Quo Vadis
por: Adadi, Amina, et al.
Publicado: (2019)

Low-intensity extracorporeal shock wave therapy for Peyronie's disease: a single-center experience
por: Abdessater, Maher, et al.
Publicado: (2021)

Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
por: Smelser, Woodson Wade, et al.
Publicado: (2017)

The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is “Safe Better than Sorry”?
por: Pradère, Benjamin, et al.
Publicado: (2020)

Peri-operative physiotherapy
por: Makhabah, Dewi Nurul, et al.
Publicado: (2013)

Peri-Operative Care
por: Kortbeek, John B.
Publicado: (2021)

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

Challenging the safety quo
por: Marriott, Craig
Publicado: (2017)

Quo vadis, Kras?
por: Schneider, Günter, et al.
Publicado: (2013)

The Quid Pro Quo
Publicado: (1869)

AERD: Quo Vadis?
por: Bosso, John V.
Publicado: (2020)

Remdesivir: Quo vadis?()
por: De Clercq, Erik
Publicado: (2021)

Quo Vadis Influenza?
por: Neumann, Gabriele, et al.
Publicado: (2021)

Quo vadis Impfpflicht?
por: Hötzenecker, Wolfram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eb0vlgq03q52nbvnv43fgli2pk